30 Years of Evidence
Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.
Featured Content
pancreatic cancer awareness
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Zhang Zunhao et al.
pancreatic cancer awareness
Long-Term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-Metastatic Pancreatic Cancer
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Bi-Yang Cao et al.
pancreatic cancer awareness
Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
Date: 2022
Treatment Technique: SIB
Platform: TomoTherapy System
Author: Zhan Shi et al.
Obliteration Rates for High-Risk Arteriovenous Malformations with Dose-Escalated Hypofractionated Radiosurgery
Sophia Shah et al. |ASTRO 2024
Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia
Jeffrey Wong et al. | ASTRO 2024
Commission Test of S7 Mode Stereotactic Radiosurgery CyberKnife System with Multileaf Collimator Based on AAPM MPPG.5a Guide
Pang Tingtian et al. | ASTRO 2024
Interested in conducting research with the CyberKnife® or Radixact® / TomoTherapy® Systems?
If you’re a member of Accuray Exchange (AEx), you can complete a collaboration application form here.
